Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Study of AJG555 in 1-year-old Patients with Chronic Constipation
jRCT2031230142Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of polyethylene glycol 3350 in chronic constipation, sponsored by EA Pharma Co., Ltd. Primary endpoint: Change in spontaneous bowel movements at Week 2. Started Jul 2023; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCT2031230142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230142.